| Literature DB >> 25279332 |
Satoshi Tsukushi1, Yoshihiro Nishida1, Hiroshi Urakawa1, Eiji Kozawa1, Naoki Ishiguro1.
Abstract
High grade soft tissue sarcomas often show histological invasion to adjacent compartment including bone and vessel. This study aimed to evaluate histological invasion in high grade soft tissue sarcomas, clarify its impact on prognosis and devise treatment strategies. We retrospectively reviewed 133 patients with non-small round cell high grade soft tissue sarcomas surgically treated between 2001 and 2011. Clinical and histological factors examined for prognostic value included age, gender, size, depth, location, adjuvant therapy and invasion to adjacent compartment. Study endpoints included overall survival rate, event free survival rate and local recurrence free survival rate, estimated by the Kaplan-Meier method. Univariate and multivariate analyses were performed using the log-rank test and Cox proportional hazards model. Local recurrence was recognized in 14 cases (11%). The 5-year overall survival rate and 5-year event free survival rate were 82.2% and 63.6% respectively. The metastasis-free survival rate at 5 years and local recurrence-free survival rate at 5 years were 69.8% and 86.8% respectively. Histological invasion to adjacent compartment was noted in 52 cases (39%), and was significantly correlated with histological type (p = 0.01), tumor size (p = 0.009), and depth (p < 0.05). In multivariate analyses, we showed that tumor size and histological invasion were significant independent predictors of OS (hazard ratio 8.1/2.5) and EFS (hazard ratio 5.5/2.2), while only tumor size was a significant independent predictor of LRFS (hazard ratio 4.0). We evaluated the relation between histological invasion and the oncological outcomes of high grade soft tissue sarcomas. In multivariate analyses, histological invasion was found to be an independent adverse prognostic factor with hazard ratios of 2.2-2.5, suggesting that a detailed assessment of these factors is essential. Histological invasion showed a correlation with tumor size and histological type, and the surgical margin should be decided based on these factors.Entities:
Keywords: Clinical outcome; Histological invasion; Prognosis; Soft tissue sarcoma
Year: 2014 PMID: 25279332 PMCID: PMC4179641 DOI: 10.1186/2193-1801-3-544
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Clinicopathological data for 133 patients with non-small round cell high grade soft tissue sarcomas
| Characteristics | All | % | With invasion | Without invasion | P-value** |
|---|---|---|---|---|---|
| (N = 133) | (N = 52) | (N = 81) | |||
| Age | |||||
| Median | 62 yr | ||||
| <60 yr | 56 | 42 | 16 | 38 | |
| ≧60 yr | 77 | 58 | 36 | 43 | p = 0.064 |
| Gender | |||||
| Male | 78 | 59 | 32 | 46 | p = 0.587 |
| Female | 55 | 41 | 20 | 35 | |
| Tumor location | |||||
| Upper extremity | 23 | 17 | 11 | 12 | |
| Lower extremity | 85 | 64 | 28 | 56 | |
| Trunk | 25 | 19 | 13 | 12 | p = 0.142 |
| Tumor depth | |||||
| Superficial | 62 | 47 | 13 | 49 | |
| Deep | 71 | 53 | 39 | 32 | p < 0.05 |
| Tumor size | |||||
| ≦5 cm | 46 | 35 | 11 | 35 | |
| >5 cm | 87 | 65 | 41 | 46 | p = 0.009 |
| Surgical margin | |||||
| R0 | 122 | 92 | 39 | 74 | |
| R1 | 11 | 8 | 13 | 7 | p < 0.05 |
| R2 | 0 | 0 | 0 | 0 | |
| Histological diagnosis | |||||
| Undifferentiated pleomorphic sarcoma | 52 | 39 | 31 | 21 | p = 0.01 |
| Liposarcoma | 23 | 17 | 4 | 19 | |
| Myxofibrosarcoma | 14 | 11 | 3 | 11 | |
| MPNST* | 14 | 11 | 5 | 9 | |
| Synovial sarcoma | 13 | 10 | 4 | 9 | |
| Leiomyosarcoma | 10 | 8 | 3 | 7 | |
| Other | 7 | 5 | 2 | 5 | |
| Continuously free of disease | 82 | 62 | 22 | 60 | |
| Alive with disease | 8 | 6 | 4 | 4 | |
| Alive and currently no evidence of disease | 18 | 14 | 10 | 8 | |
| Dead of disease | 22 | 17 | 14 | 8 | |
| Dead of other disease | 3 | 2 | 2 | 1 | |
| Overall survival rate at 5 years | 82.2% | 69.6% | 90.3% | ||
| Event-free survival rate at 5 years | 63.6% | 41.3% | 77.5% | ||
| Metastasis-free survival rate at 5 years | 69.8% | 53.0% | 80.8% | ||
| Local recurrence-free rate at 5 years | 86.8% | 77.8% | 92.1% |
*MPNST; malignant peripheral nerve sheath tumor.
**The risk factor of invasion was assessed using Fisher's exact test or the Chi-square test.
Figure 1Kaplan–Meier life table analysis of overall survival of high grade soft tissue sarcoma patients with or without histological invasion. For overall survival histological invasion (p = 0.01) was a significant unfavorable prognostic factor.
Figure 2Kaplan–Meier life table analysis of event free survival of high grade soft tissue sarcoma patients with or without histological invasion. For event free survival histological invasion (p < 0.001) was a significant unfavorable prognostic factor.
Figure 3Kaplan–Meier life table analysis of local recurrence free survival of high grade soft tissue sarcoma patients with or without histological invasion. For local recurrence free survival histological invasion (p = 0.025) was a significant unfavorable prognostic factor.
Univariate analysis for prognostic factors in overall survival, event free survival and local recurrence free survival
| Factors | No. of patients | Overall 5-year survival rate | P-value | Event free 5-year survival rate | P-value | Local recurrence free 5-year survival rate | P-value |
|---|---|---|---|---|---|---|---|
| Age | |||||||
| ≧60 yr | 56 | 80.8% | p = 0.298 | 64.4% | p = 0.711 | 87.0% | p = 0.926 |
| <60 yr | 77 | 84.5% | 62.0% | 86.5% | |||
| Gender | |||||||
| Male | 78 | 78.7% | p = 0.362 | 55.4% | p = 0.067 | 96.3% | p = 0.040 * |
| Female | 55 | 86.9% | 75.8% | 80.5% | |||
| Tumor location | |||||||
| Extremity | 108 | 83.4% | p = 0.271 | 64.9% | p = 0.874 | 89.7% | p = 0.075 |
| Trunk | 25 | 76.6% | 58.3% | 74.4% | |||
| Tumor depth | |||||||
| Superficial | 62 | 94.2% | p < 0.001* | 82.3% | p < 0.001* | 95.7% | p < 0.01* |
| Deep | 71 | 71.0% | 45.7% | 77.4% | |||
| Tumor size | |||||||
| ≦5 cm | 46 | 100.0% | p < 0.001* | 90.8% | p < 0.001* | 100.0% | p < 0.01* |
| >5 cm | 87 | 71.6% | 48.1% | 78.1% | |||
| Histological invasion | |||||||
| Yes | 52 | 69.6% | p = 0.01* | 41.3% | p < 0.001* | 77.8% | p = 0.025* |
| No | 81 | 90.3% | 77.5% | 92.1% | |||
| Adjuvant radiotherapy | |||||||
| Yes | 32 | 76.5% | p = 0.964 | 57.1% | p = 0.538 | 78.7% | p = 0.128 |
| No | 101 | 84.7% | 66.1% | 90.1% | |||
| Adjuvant chemotherapy | |||||||
| Yes | 28 | 88.0% | p = 0.596 | 66.2% | p = 0.952 | 91.8% | p = 0.625 |
| No | 105 | 81.3% | 63.4% | 86.0% |
*Statistically significant difference.
Multivariate cox proportional analysis for prognostic factors in overall survival, event free survival and local recurrence free survival
| Factors | Overall survival | Event free survival | Local recurrence free survival | |||
|---|---|---|---|---|---|---|
| Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | |
| Age | ||||||
| ≧60 yr | 1 (referent) | 0.959 | ||||
| <60 yr | 1.0 (0.33-2.79) | |||||
| Tumor depth | ||||||
| Superficial | 1 (referent) | 0.961 | 1 (referent) | 0.228 | 1 (referent) | 0.863 |
| Deep | 1.0 (0.39-2.35) | 1.5 (0.78-2.81) | 1.1 (0.35-3.47) | |||
| Tumor size | ||||||
| ≦5 cm | 1 (referent) | 0.015* | 1 (referent) | 0.002* | 1 (referent) | 0.006* |
| >5 cm | 8.1 (2.46-26.42) | 5.5 (1.90-15.75) | 4.0 (1.38-10.13) | |||
| Histological invasion | ||||||
| No | 1 (referent) | 0.036* | 1 (referent) | 0.012* | 1 (referent) | 0.08 |
| Yes | 2.5 (1.35-4.71) | 2.2 (1.19-4.16) | 1.8 (1.11-3.15) | |||
*Statistically significant difference.